420 with CNW — Marijuana Reclassification Eases Some Industry Hurdles
Cannabis rescheduling in the U.S. could reshape scientific research and parts of the industry, though key questions remain about how the change will be carried out. Under a final rule issued by the Office of the Attorney General, federally approved drug products containing marijuana would be placed in Schedule III of the CSA. This represents a significant change from the current Schedule I status, a category reserved for substances considered highly dangerous and lacking accepted medical use. Moving cannabis into Schedule III places it alongside drugs such as ketamine and codeine, signaling recognition of its therapeutic potential. Researchers say the adjustment could ease some of the strict requirements that have long complicated cannabis studies. Daniele Piomelli, a professor of anatomy and…

















